Stay updated on Omalizumab in CRSwNP: Clinical Trial
Sign up to get notified when there's something new on the Omalizumab in CRSwNP: Clinical Trial page.

Latest updates to the Omalizumab in CRSwNP: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 is now displayed; the government funding lapse notice and the previous 3.4.1 revision have been removed.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a funding-status notice and updated the page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.5%

- Check28 days agoChange DetectedNew UI/metadata updates include a 'Show glossary' option, a 'Last Update Submitted that Met QC Criteria' field, and a 'No FEAR Act Data' label with 'Revision: v3.4.0'. These are minor changes that do not modify core study content.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing the previous v3.3.3. This is a minor update with no visible impact on study information or user interactions.SummaryDifference0.1%

- Check63 days agoChange DetectedThe Locations section now includes Maryland as a study site, and the footer revision updated to v3.3.3; the prior Maryland Locations heading and HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%

- Check92 days agoChange DetectedFooter revision updated from v3.2.0 to v3.3.2; this is a minor site update that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Omalizumab in CRSwNP: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Omalizumab in CRSwNP: Clinical Trial page.